Zydus Lifesciences Q3 FY24 PAT up 26.8%
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
NEIAFMR to be developed as the national hub for folk medicine
Subscribe To Our Newsletter & Stay Updated